Pusen Excellence Biotechnology

Pusen Excellence Biotechnology is a clinical-stage biopharmaceutical company based in Beijing, China, specializing in the discovery and development of innovative antibody-based therapeutics for oncology and autoimmune diseases. The company leverages a proprietary high-throughput screening platform to identify high-affinity monoclonal and multi-specific antibodies targeting immune checkpoints and tumor-associated antigens. Its pipeline includes several next-generation immunotherapy candidates, such as bispecific antibodies and antibody-drug conjugates, designed to overcome resistance to current standard-of-care treatments. Pusen Excellence focuses on advancing its lead programs through early-phase clinical trials while establishing strategic collaborations to accelerate its global development footprint.